Johnson & Johnson Is Reinventing The Party Drug Ketamine To Treat Depression. comments, called-out. Comment Now. Follow Comments Following Comments Unfollow Comments.

Johnson & Johnson, the world's biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017.

(The follicularly-challenged central banker must truly be tearing his hair out right about now, for Rogaine maker Johnson & Johnson (JNJ) has just been assigned a �Sell� rating.) Thus in the space of one spacy session, investors learned the age-old ...

The world's biggest maker of healthcare products, Johnson & Johnson (NYSE:JNJ) is ready to prove itself again. With its status as fastest growing pharmaceutical business in 2012, it doesn't come as a surprise that the drugmaker has big plans for the ...

We have checkups for our bodies, our teeth, and even our cars. Why not do the same for our stocks? With that in mind, here is an inaugural monthly checkup for Johnson & Johnson (NYSE: JNJ ) stock. Let's look at three key areas to find out J&J's stock ...

Shares of Johnson & Johnson (JNJ) have been in a solid uptrend throughout 2013. As shown in the chart below, the stock looks extended now, so investors should wait for a pullback.

Johnson & Johnson (JNJ) unit Janssen Pharmaceutical Co. said it plans to submit more than 10 new product filings and more than 25 significant brand line extensions by 2017, which would amount to roughly the same number of new product filings it made in ...

The VCIG-Live topic this month is Cloud Managed Services.The panel will address issues such as scalability, infrastructure costs, BYOD, and cloud services providers.

Today, we'll dive deeper into health care and consumer products giant Johnson & Johnson (NYSE: JNJ ) . Owning Johnson & Johnson stock as a dividend play makes all kinds of sense, because the company scores better than the Dow Jones Industrial ...

Johnson & Johnson (NYSE:JNJ) has experienced a decrease in enthusiasm from smart money in recent months. If you'd ask most traders, hedge funds are viewed as unimportant, old investment tools of the past.